VF
STLNW

Virtu Financial’s Starling Oncology Warrant STLNW Stock Holding History

Virtu Financial’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,749
Closed – – 1888
2024
Q2 		$0 Buy
+12,749
New +$983 ﹤0.01% 1882
2022
Q1 		– Sell
-12,603
Closed -$9K – 2036
2021
Q4 		$9K Buy
+12,603
New +$15.6K ﹤0.01% 1587

Other funds holding STLNW

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $284M AUM 24.22% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Virtu Financial's STLNW Position: Q3 2024 in Review

Virtu Financial sold out of Starling Oncology Warrant (STLNW) in Q3 2024, closing a stake of 12,749 shares.

Virtu Financial first reported a position in STLNW in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 15 funds tracked by Wall St. Rank hold STLNW as of Q3 2024.

  • Virtu Financial reported no remaining Starling Oncology Warrant position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 12,749 Starling Oncology Warrant shares in Q3 2024.
  • Virtu Financial first reported a position in Starling Oncology Warrant in Q4 2021 and held it in 2 quarters.
  • Virtu Financial's Starling Oncology Warrant position peaked at $9K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.